Literature DB >> 3907806

Blood pressure responsiveness during the development of hypertension in the conscious spontaneously hypertensive rat.

C B Toal, F H Leenen.   

Abstract

Blood pressure responsiveness to iv noradrenaline and angiotensin II was studied in conscious, freely moving, age-matched spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats from 4 to 16 weeks of age. At 4 and 6 weeks the SHR showed small, but nonsignificant increases in responsiveness compared with WKY to both noradrenaline and angiotensin II. At 8 weeks they exhibited similar responses to the WKY. Subsequently, at 12 and 16 weeks decreased responsiveness to noradrenaline (nonsignificant) and angiotensin II (p less than 0.05 at 12 and 16 weeks) was observed in SHR versus WKY. At 16 weeks of age, hexamethonium caused potentiation of the blood pressure response to noradrenaline and angiotensin II, but to the same degree in the two strains. Captopril at this age did not elicit potentiation to noradrenaline or angiotensin II in either strain. These results indicate that there is no rise in blood pressure responsiveness to circulating pressor agents, parallel to the development of hypertension in SHR. Increased receptor occupancy or more active attenuating reflexes in SHR versus WKY appear not to be involved in the absence of hyperresponsiveness in intact conscious SHR at 16 weeks of age.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907806     DOI: 10.1139/y85-208

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  2 in total

1.  Evidence for functional alterations in the skeletal muscle mechanoreflex and metaboreflex in hypertensive rats.

Authors:  Anna K Leal; Maurice A Williams; Mary G Garry; Jere H Mitchell; Scott A Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-18       Impact factor: 4.733

2.  Modulation of vascular function by neuropeptide Y during development of hypertension in spontaneously hypertensive rats.

Authors:  Z Zukowska-Grojec; M Golczynska; G H Shen; A Torres-Duarte; M Haass; C Wahlestedt; A K Myers
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.